Publications by authors named "Terri Cameron"

Claim this Profile
P
Population Pharmacokinetic Modeling of Lucitanib in Patients with Advanced Cancer.
Mingxiang Liao, Jie Zhou, Kenton Wride, Denise Lepley, Terri Cameron

Eur J Drug Metab Pharmacokinet· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintenance treatment with rucaparib for recurrent ovarian carcinoma in ARIEL3, a randomized phase 3 trial: The effects of best response to last platinum-based regimen and disease at baseline on efficacy and safety.
Ana Oaknin, Amit M Oza, Domenica Lorusso, Carol Aghajanian, Andrew Dean, Terri Cameron

Cancer Med· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rucaparib maintenance treatment for recurrent ovarian carcinoma: the effects of progression-free interval and prior therapies on efficacy and safety in the randomized phase III trial ARIEL3.
Andrew R Clamp, Domenica Lorusso, Amit M Oza, Carol Aghajanian, Ana Oaknin, Terri Cameron

Int J Gynecol Cancer· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-Centered Outcomes in ARIEL3, a Phase III, Randomized, Placebo-Controlled Trial of Rucaparib Maintenance Treatment in Patients With Recurrent Ovarian Carcinoma.
Amit M Oza, Domenica Lorusso, Carol Aghajanian, Ana Oaknin, Andrew Dean, Terri Cameron

J Clin Oncol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of age on efficacy, safety and patient-centered outcomes with rucaparib: A post hoc exploratory analysis of ARIEL3, a phase 3, randomized, maintenance study in patients with recurrent ovarian carcinoma.
Nicoletta Colombo, Amit M Oza, Domenica Lorusso, Carol Aghajanian, Ana Oaknin, Terri Cameron

Gynecol Oncol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rucaparib for patients with platinum-sensitive, recurrent ovarian carcinoma (ARIEL3): post-progression outcomes and updated safety results from a randomised, placebo-controlled, phase 3 trial.
Jonathan A Ledermann, Amit M Oza, Domenica Lorusso, Carol Aghajanian, Ana Oaknin, Terri Cameron

Lancet Oncol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor activity of the poly(ADP-ribose) polymerase inhibitor rucaparib as monotherapy in patients with platinum-sensitive, relapsed, -mutated, high-grade ovarian cancer, and an update on safety.
Rebecca S Kristeleit, Ana Oaknin, Isabelle Ray-Coquard, Alexandra Leary, Judith Balmaña, Terri Cameron

Int J Gynecol Cancer· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on: "Cost-Effectiveness of Niraparib Versus Routine Surveillance, Olaparib and Rucaparib for the Maintenance Treatment of Patients with Ovarian Cancer in the United States".
Katrine Wallace, Sandra Goble, Jeff Isaacson, Lara Maloney, Terri Cameron

Pharmacoeconomics· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial.
Robert L Coleman, Amit M Oza, Domenica Lorusso, Carol Aghajanian, Ana Oaknin, Terri Cameron

Lancet· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re: 'Better data ≫ Bigger data'.
Rachel Ellaway, Martin Pusic, Robert Galbraith, Terri Cameron

Med Teach· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing the role of big data and analytics in health professional education.
Rachel H Ellaway, Martin V Pusic, Robert M Galbraith, Terri Cameron

Med Teach· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Curriculum inventory: Modeling, sharing and comparing medical education programs.
Rachel H Ellaway, Susan Albright, Valerie Smothers, Terri Cameron, Timothy Willett

Med Teach· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toward a common taxonomy of competency domains for the health professions and competencies for physicians.
Robert Englander, Terri Cameron, Adrian J Ballard, Jessica Dodge, Janet Bull

Acad Med· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Wolman disease/cholesteryl ester storage disease: efficacy of plant-produced human lysosomal acid lipase in mice.
Hong Du, Terri L Cameron, Stephen J Garger, Gregory P Pogue, Lee A Hamm

J Lipid Res· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shared governance: making the transition in practice and perception.
Berthenya Dunbar, Bonnie Park, Mary Berger-Wesley, Terri Cameron, Barbara T Lorenz

J Nurs Adm· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protection of rabbits against cutaneous papillomavirus infection using recombinant tobacco mosaic virus containing L2 capsid epitopes.
Kenneth E Palmer, Ann Benko, Sarah A Doucette, Terri I Cameron, Tiffany Foster

Vaccine· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementing an online curriculum management database in a problem-based learning curriculum.
Joshua Jacobs, Albert Salas, Terri Cameron, Gwen Naguwa, Richard Kasuya

Acad Med· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized trial of two intravenous schedules of the topoisomerase I inhibitor liposomal lurtotecan in women with relapsed epithelial ovarian cancer: a trial of the national cancer institute of Canada clinical trials group.
Graham G Dark, A Hilary Calvert, Robert Grimshaw, Christopher Poole, Ken Swenerton, Terri Cameron

J Clin Oncol· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Southern Illinois University School of Medicine.
Amber Barnhart, Nancy McCann-Stone, Terri Cameron, Anne J Gunderson, John M Tomkowiak

Acad Med· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individualized human scFv vaccines produced in plants: humoral anti-idiotype responses in vaccinated mice confirm relevance to the tumor Ig.
Alison A McCormick, Stephen J Reinl, Terri I Cameron, Fakhrieh Vojdani, Michele Fronefield

J Immunol Methods· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CurrMIT: a tool for managing medical school curricula.
Albert A Salas, M Brownell Anderson, Lisa LaCourse, Robert Allen, Chris S Candler, Terri Cameron

Acad Med· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I and pharmacologic study of liposomal lurtotecan, NX 211: urinary excretion predicts hematologic toxicity.
Diederik F S Kehrer, Annelies M Bos, Jaap Verweij, Harry J Groen, Walter J Loos, Terri Cameron

J Clin Oncol· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis